Matches in Wikidata for { <http://www.wikidata.org/entity/Q91239550> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q91239550 description "2018 թվականին հրատարակված գիտական հոդված" @default.
- Q91239550 description "article scientifique (publié 2018)" @default.
- Q91239550 description "articolo scientifico (pubblicato il 2018)" @default.
- Q91239550 description "artigo científico (publicado na 2018)" @default.
- Q91239550 description "artikull shkencor i botuar më 01 janar 2018" @default.
- Q91239550 description "artículo científico publicado en 2018" @default.
- Q91239550 description "artículu científicu espublizáu en xineru de 2018" @default.
- Q91239550 description "im Jahr 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91239550 description "scientific article published on 01 January 2018" @default.
- Q91239550 description "wetenschappelijk artikel" @default.
- Q91239550 description "наукова стаття, опублікована 1 січня 2018" @default.
- Q91239550 description "научна статия" @default.
- Q91239550 name "Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes" @default.
- Q91239550 name "Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes" @default.
- Q91239550 name "Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes" @default.
- Q91239550 type Item @default.
- Q91239550 label "Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes" @default.
- Q91239550 label "Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes" @default.
- Q91239550 label "Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes" @default.
- Q91239550 prefLabel "Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes" @default.
- Q91239550 prefLabel "Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes" @default.
- Q91239550 prefLabel "Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes" @default.
- Q91239550 P1104 Q91239550-E85F4DBE-EAC8-4D2F-A81C-C34649487F52 @default.
- Q91239550 P1433 Q91239550-37BDF3D2-D1C6-419C-A40A-8968A79FAAEF @default.
- Q91239550 P1476 Q91239550-0C1B1B3D-29EB-4DF5-B936-764A5CF581F1 @default.
- Q91239550 P2093 Q91239550-0EFDD7EC-9A71-4FEE-8CF3-BE1D29838E7D @default.
- Q91239550 P2093 Q91239550-18C35CEC-4554-4CA1-9CA2-996A0C0BB1FC @default.
- Q91239550 P2093 Q91239550-4F07379D-92B3-4760-8CB3-F030A3B1F1AC @default.
- Q91239550 P2093 Q91239550-9190FD72-1575-471B-9E9E-C474BC499E95 @default.
- Q91239550 P2093 Q91239550-EA3752F7-C381-4FA8-AB90-23AB36909DDD @default.
- Q91239550 P2093 Q91239550-F9C5179C-C53F-45FC-81AE-55C91C9B9D8F @default.
- Q91239550 P304 Q91239550-673F53CA-05A0-4FD6-A4DA-23964F04C870 @default.
- Q91239550 P31 Q91239550-E5E76B10-3B2A-40D0-A66E-EBCFEE280F53 @default.
- Q91239550 P356 Q91239550-0B029C2C-07EC-4401-A3B3-D5FD7D73B462 @default.
- Q91239550 P433 Q91239550-D01F03B7-AA3C-4A15-A488-8CE2DEAF8C4C @default.
- Q91239550 P478 Q91239550-4B37BD40-F060-4BAF-AEB7-2A34320BEEC4 @default.
- Q91239550 P577 Q91239550-16BA95D7-9539-46A2-8CEB-0F2003404213 @default.
- Q91239550 P698 Q91239550-A8FDDEFB-8B79-46A0-82E6-7A2DF2D401CF @default.
- Q91239550 P921 Q91239550-58CCC1F9-7908-4BBE-B33C-5BD4A000D57D @default.
- Q91239550 P356 BLL_2018_139 @default.
- Q91239550 P698 30686015 @default.
- Q91239550 P1104 "+8" @default.
- Q91239550 P1433 Q15766670 @default.
- Q91239550 P1476 "Increased lipocalin-2 vs reduced oxytocin in relation with adiposity, atherogenicity and hematological indices in metabolic syndrome patients with and without prediabetes" @default.
- Q91239550 P2093 "K O Tofiq" @default.
- Q91239550 P2093 "L Halaseh" @default.
- Q91239550 P2093 "M Suyagh" @default.
- Q91239550 P2093 "N Bulatova" @default.
- Q91239550 P2093 "S Alalawi" @default.
- Q91239550 P2093 "V Kasabri" @default.
- Q91239550 P304 "762-769" @default.
- Q91239550 P31 Q13442814 @default.
- Q91239550 P356 "10.4149/BLL_2018_139" @default.
- Q91239550 P433 "12" @default.
- Q91239550 P478 "119" @default.
- Q91239550 P577 "2018-01-01T00:00:00Z" @default.
- Q91239550 P698 "30686015" @default.
- Q91239550 P921 Q657193 @default.